BE852252A - Nouveaux 5-(1,1-diphenyl-3-(5 ou 6-hydroxy ou-alcanoyloxy inferieur-2-aza-2-bicyclo(2,2,2)octoyl)propyl)-2-alkyl)1,3,4-oxodiazoles - Google Patents

Nouveaux 5-(1,1-diphenyl-3-(5 ou 6-hydroxy ou-alcanoyloxy inferieur-2-aza-2-bicyclo(2,2,2)octoyl)propyl)-2-alkyl)1,3,4-oxodiazoles

Info

Publication number
BE852252A
BE852252A BE175614A BE175614A BE852252A BE 852252 A BE852252 A BE 852252A BE 175614 A BE175614 A BE 175614A BE 175614 A BE175614 A BE 175614A BE 852252 A BE852252 A BE 852252A
Authority
BE
Belgium
Prior art keywords
oxodiazoles
alcanoyloxy
inferieur
octoyl
aza
Prior art date
Application number
BE175614A
Other languages
English (en)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of BE852252A publication Critical patent/BE852252A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BE175614A 1976-03-10 1977-03-09 Nouveaux 5-(1,1-diphenyl-3-(5 ou 6-hydroxy ou-alcanoyloxy inferieur-2-aza-2-bicyclo(2,2,2)octoyl)propyl)-2-alkyl)1,3,4-oxodiazoles BE852252A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/665,609 US4013668A (en) 1976-03-10 1976-03-10 5-(1,1-diphenyl-3-(5- or 6-hydroxy-2-azabicyclo(2.2.2)oct-2-yl)propyl)-2-alkyl-1,3,4-oxadiazoles and related compounds

Publications (1)

Publication Number Publication Date
BE852252A true BE852252A (fr) 1977-09-09

Family

ID=24670819

Family Applications (1)

Application Number Title Priority Date Filing Date
BE175614A BE852252A (fr) 1976-03-10 1977-03-09 Nouveaux 5-(1,1-diphenyl-3-(5 ou 6-hydroxy ou-alcanoyloxy inferieur-2-aza-2-bicyclo(2,2,2)octoyl)propyl)-2-alkyl)1,3,4-oxodiazoles

Country Status (17)

Country Link
US (1) US4013668A (fr)
JP (1) JPS5951955B2 (fr)
AT (1) AT350559B (fr)
AU (1) AU505650B2 (fr)
BE (1) BE852252A (fr)
CA (1) CA1078386A (fr)
CH (1) CH627467A5 (fr)
DE (1) DE2710242A1 (fr)
DK (1) DK103777A (fr)
ES (1) ES456687A1 (fr)
FR (1) FR2343740A2 (fr)
GB (1) GB1524653A (fr)
IE (1) IE44639B1 (fr)
NL (1) NL7702537A (fr)
NZ (1) NZ183540A (fr)
SE (1) SE7702640L (fr)
ZA (1) ZA771428B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0241180A (ja) * 1988-07-29 1990-02-09 Shinji Kanda 耐火避難用カプセル
EP0499313B1 (fr) * 1991-02-11 1997-06-11 MERCK SHARP & DOHME LTD. Composés azabicycliques, compositions pharmaceutiques les contenant et leur utilisation thérapeutique
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US6353004B1 (en) 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
ES2528669T3 (es) * 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Formulaciones farmacéuticas que contienen metilnaltrexona
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) * 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
PL2139890T3 (pl) * 2007-03-29 2014-11-28 Wyeth Llc Antagoniści obwodowych receptorów opioidowych i ich zastosowania
PE20090700A1 (es) * 2007-03-29 2009-07-13 Progenics Pharm Inc Compuestos heterociclicos como antagonistas del receptor opioide periferico
BRPI0809579B8 (pt) 2007-03-29 2021-05-25 Progenics Pharm Inc formas cristalinas e seus usos
WO2009099411A1 (fr) 2008-02-06 2009-08-13 Progenics Pharmaceuticals, Inc. Préparation et utilisation de (r),(r)-2,2'-bis-méthylnaltrexone
WO2010029313A1 (fr) * 2008-09-11 2010-03-18 Summit Corporation Plc. Composés anti-infectieux
CA2676881C (fr) 2008-09-30 2017-04-25 Wyeth Antagonistes de recepteurs opioides peripheriques, et leurs utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917615A (en) * 1974-04-01 1975-11-04 Searle & Co 1,1-Diaryl-1-oxadiazol-alkylamines

Also Published As

Publication number Publication date
NZ183540A (en) 1980-05-27
DK103777A (da) 1977-09-11
AU2302977A (en) 1978-09-14
AT350559B (de) 1979-06-11
SE7702640L (sv) 1977-09-11
AU505650B2 (en) 1979-11-29
IE44639L (en) 1977-09-10
CH627467A5 (de) 1982-01-15
DE2710242A1 (de) 1977-09-22
CA1078386A (fr) 1980-05-27
JPS52108999A (en) 1977-09-12
JPS5951955B2 (ja) 1984-12-17
GB1524653A (en) 1978-09-13
ATA157477A (de) 1978-11-15
FR2343740B2 (fr) 1980-06-20
FR2343740A2 (fr) 1977-10-07
ZA771428B (en) 1978-10-25
NL7702537A (nl) 1977-09-13
IE44639B1 (en) 1982-02-10
US4013668A (en) 1977-03-22
ES456687A1 (es) 1978-02-01

Similar Documents

Publication Publication Date Title
BE852252A (fr) Nouveaux 5-(1,1-diphenyl-3-(5 ou 6-hydroxy ou-alcanoyloxy inferieur-2-aza-2-bicyclo(2,2,2)octoyl)propyl)-2-alkyl)1,3,4-oxodiazoles
FI773448A7 (fi) Foerfarande foer framstaellning av trisubstituerade 1-fenyl-2,3,4,5-tetra-hydro-1h-3-benzazepinfoereningar
NO771391L (no) Funksjonelle proteiner.
FI782081A7 (fi) N-substituerade estrar av 9,10-dihydrolyserinsyror och foerfarande foer deras framstaellning
SE423671B (sv) Sopapparat, serskilt mattsopapparat
FI73979B (fi) Framstaellning av och mellanprodukter till 2,6-dialkoxibensamider.
DE3175317D1 (de) 5-(2,6-dichloro-4-trifluoromethyl-phenoxy)-2-nitrobenzaldehyde-diacetacylal
BE850239A (fr) Nouveaux triazolyl-0,n-acetals acyles
HU173579B (hu) Sposob poluchenija asimmetricheskikh 1,3-dvoe-zamehhennykh nitrozo-mochevin
NO771357L (no) L}sering.
IT7919536A0 (it) Coloranti eterociclici.
SE7708989L (sv) Stabiliserad 1,1,1-trikloretankomposition
BE856409A (fr) 2,6-methano-2h-1-benzoxocines
FI773466A7 (fi) Substituerade 2,1,3-bentsotiadiazinfoereningar
BE854184A (fr) 1,2,6-thiadiazinones
ATA457479A (de) Stabilisietes 1,1,1-trichloraethan
SE418052B (sv) Sopapparat, serskilt mattsopapparat
ATA457579A (de) Stabilisiertes 1,1,1-trichloraethan
HU173509B (hu) Sposob poluchenija proizvodnykh 1,2-benzo-tiazin-3-karboksamida
BE851630A (fr) Nouveaux 1-sulfonylbenzimidazoles 5(6)-substitues
HU174697B (hu) Sposob poluchenija novykh proizvodnykh 6,7-dimetoksi-1,2,3,4-tetragidro-1-izokinolin-acetamida
FI772434A7 (fi) Foerfarande foer framstaellning av 2,3-dikloranisol
IT1077596B (it) 1,3-diidro-1'-dimetilfosfinilalchil-3-fenilspiro isobenzofurani
BE851751A (fr) 5,6-deshydropenicillines
FI803041A7 (fi) Framstaellning av 2-oxo-dihydrobenso/d/1,3/oxaziner

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: G.D. SEARLE & CO.

Effective date: 19850309